BENZENO SHARON bought ADPT
June 29, 2026 · Form 4 insider transaction
BENZENO SHARON bought 1,837 shares of Adaptive Biotechnologies Corporation at $12.14 per share, a transaction worth $22.3K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
1,837
Price
$12.14
Total value
$22.3K
InsiderBENZENO SHARON
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateJune 29, 2026
Filing dateJune 30, 2026
Shares owned after274,588
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 12, 2025.